Imprint

Debates on Bladder Cancer 

ISSN 1869-7232

published by Forum Verlag Dr. Wolfgang Otto

Postfach 100728

93007 Regensburg

Germany

phone 0049 (0) 941 70 55 08 40

www.forum-verlag-otto.de

 

Consulting and design: seitenwind.com

Blumenstr. 18

93055 Regensburg

Germany

phone 0049 (0) 941 64 64 56 0 

fax 0049 (0) 941 64 64 56 20


 

CMS generated by ARANES GmbH & Co. KG

Etzweg 9

93089 Aufhausen

Germany

phone 0049 (0) 9454 94 90 54 0

fax 0049 (0) 9454 94 90 54 99

www.aranes.de

 

 

Disclaimer

All content of the website www.debates-on-bladder-cancer.com (DOBC) including layout, images and texts is the property of Forum Verlag (FV) and cooperative companies. They are protected by copyright and other intellectual property laws. It is provided for free for private, non commercial use by providing appropriate copyright and property notifications. In contrast it is not allowed to copy, modify, publish or sell deriving works from the contents without prior written permission from FV. Particular questions for permission to publish, reproduce or make derivative works from the contents should be directed to FV.

FV is not responsible for the availability and the contents of external links. Conditions of these linked sites may differ from DOBC and should be reviewed before the use of these sites.

Your contributions to DOBC may not contain any illegal, personally violating, pornographic, or hateful contents. There should not be any errors, viruses or other problematic contents be included to the contributions.

Like any field of science medicine is constantly subject to changes. Research and clinical experience expand our knowledge, especially when treatment and medication are concerned. As far as dosage or an application is mentioned in the contents of DOBC, the reader may rely on the authors having taken great care that this information meets the standard of knowledge on completion of the brochure. However, for details of dosage instructions and forms of application FV cannot take any responsibility. Every user is urged to check by carefully studying the patient information sheet and, when required, after consulting a specialist, if the given recommendation of dosage or the consideration of contraindications differs from details in articles on DOBC. Such a check is especially important for preparations that are rarely used, or those that have only recently been introduced to the market. Each dosage or application is effected at the user’s own risk.

No responsibility is assumed by FV for any injury or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any ideas, instructions, methods, products or procedures contained in DOBC.

By using the service of DOBC you agree to indemnify FV and its affiliates harmless from any losses, damages and costs, including, without limitation, reasonable attorneys' fees, arising from your use of the content.

FV reserves the right to modify these conditions at any time and without prior notice. Changes of the conditions will be published in this place.

© Forum Verlag Dr. Wolfgang Otto, September 2009. All rights reserved.

 

MOST ACCESSED SEARCH ITEMS
BCG T1G3 Bastian
Original articles
Original articles have a 3,000 word limit. Review articles have a 5,000 word limit (excluding references). Articles must be divided into the sections Background, Methods, Results, Discussion and Concl
More...
Case reports
Case reports have a 1,500 word limit (excluding references) and must be sectioned into Background, Case Presentation and Discussion. The number of authors and references is not limited. Every article
More...
Poster Journal
The article has a 1,200 word limit (excluding references) and must be sectioned into Introduction, Methods, Results and Conclusions. Number of authors (10) and references (15) is limited. Every articl
More...
Conference reports
Articles are written by invitation of the Editors-in-chief. Manuscript length and format are not limited. Every article must be preceded by an Abstract. At the authorís request, reports about German-s
More...
Uroscope
Presentations of new diagnostic or therapeutic approaches and commentaries of experts on scientific research on bladder cancer by invitation of the Editors-in-chief. Articles must be sectioned into Ba
More...